The ACR published new recommendations for the management of glucocorticoid-induced osteoporosis (GIOP) in the November issue of Arthritis Care & Research. These guidelines have been endorsed by the American Society for Bone and Mineral Research. They apply to adult patients receiving oral glucocorticoid therapy.
Search results for: osteoporosis
Coding Corner Question
December’s Coding Challenge
Drug Updates
Information on New Approvals and Medication Safety
DEXA Champion Visits Local Rheumatologist
Sen. Blanche Lincoln (D-Ark.) visited the Arthritis Center of the Ozarks in Fayetteville, Ark., in August to speak with local rheumatologist Michael Saitta, MD, to discuss the importance of access to osteoporosis screenings.
Quadruple-threat Rheumatologist
In Norway and on the international front, Tore Kvien, MD, PhD, has propelled clinical research to new levels
Coding Corner Question
October’s Coding Challenge
Drug Updates
Information on New Approvals and Medication Safety
Research Offers Hope of New Therapies to Prevent Bone Loss and Destruction
A study recently published in Annals of the Rheumatic Diseases shows promise for potential new therapies to prevent bone loss and bone destruction in patients with rheumatoid arthritis (RA).
Our Commitment to Research
The ACR has a wide range of programs to support investigations in rheumatology
Advocating for Arthritis: My First Time on the Hill
Amidst the most momentous week of the year’s tumultuous healthcare reform activities, we arrived in Washington, D.C., for the annual ACR Advocates for Arthritis Capitol Hill Fly-In. This was to be my first visit to Congress. Although my alma mater, Georgetown University, was a short distance from the Capitol dome, as a student I had little interest in the political process—particularly as it related to medicine. Now, however, as a young rheumatologist, I am increasingly aware of the impact health policy has on my daily practice. I have also watched the healthcare reform debate unfold over the last year, recognizing that this is a critical time for physicians to be vocal and active. There is a great deal at stake, and we are surrounded daily by the very issues debated in Washington. Why not take our opinions directly to the decision makers?
- « Previous Page
- 1
- …
- 47
- 48
- 49
- 50
- 51
- …
- 58
- Next Page »